TrialMalaria journal2024

Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials.

Alphonse Ouédraogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.